bleomycin injection
cipla usa inc. - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin for injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: squamous cell carcinoma: head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. the response to bleomycin for injection is poorer in patients with previously irradiated head and neck cancer. lymphomas: hodgkin's disease, non-hodgkin's lymphoma. testicular carcinoma: embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin for injection has also been shown to be useful in the management of: malignant pleural effusion: bleomycin for injection is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin for injection is contraindicated in patients who have demonstrated
bleomycin injection, powder, lyophilized, for solution
hospira, inc. - bleomycin sulfate (unii: 7dp3ntv15t) (bleomycin - unii:40s1vhn69b) - bleomycin for injection should be considered a palliative treatment. it has been shown to be useful in the management of the following neoplasms either as a single agent or in proven combinations with other approved chemotherapeutic agents: squamous cell carcinoma head and neck (including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingivae, epiglottis, skin, larynx), penis, cervix, and vulva. the response to bleomycin is poorer in patients with previously irradiated head and neck cancer. lymphomas hodgkin's disease, non-hodgkin's lymphoma. testicular carcinoma embryonal cell, choriocarcinoma, and teratocarcinoma. bleomycin has also been shown to be useful in the management of: malignant pleural effusion bleomycin is effective as a sclerosing agent for the treatment of malignant pleural effusion and prevention of recurrent pleural effusions. bleomycin for injection is contraindicated in patients who have demonstrated a hypersensitive or an idiosyncratic reaction to i
bleomycin sulphate
hospira uk ltd - bleomycin sulfate - unknown - 15000iu/vi %v/v
daivonex scalp solution 50 mcg/ml
leo pharma asia pte ltd - calcipotriol - solution - 50 mcg/ml
daivonex cream 50 mcg/g
leo pharma asia pte ltd - calcipotriol - cream - 50 mcg/g
bleomycin for injection usp powder for solution
pfizer canada ulc - bleomycin (bleomycin sulfate) - powder for solution - 15unit - bleomycin (bleomycin sulfate) 15unit - antineoplastic agents
atormac 10 (atorvastatin film coated tablet 10mg)
macleods pharmaceuticals sdn. bhd. - atorvastatin calcium trihydrate -
atormac 40 (atorvastatin film coated tablet 40mg)
macleods pharmaceuticals sdn. bhd. - atorvastatin calcium trihydrate -
evra
trima israel pharmaceutical products maabarot ltd - ethinylestradiol; norelgestromin - patches - norelgestromin 6 mg; ethinylestradiol 0.6 mg - norelgestromin and estrogen - norelgestromin and estrogen - female contraception. evra is intended for women of fertile age.
macrosalb 2.5 mg kit for radiopharmaceutical preparation
medi-radiopharma ltd 2030 erd szamos st. 10-12, hungary - kit for radiopharmaceutical preparation - macroaggregated human albumin 2.5 mg - diagnostic radiopharmaceuticals